Automated In Situ Hybridization: Diagnostic and Research Applications

Although in situ hybridization has been in use for almost 30 years, its technically demanding nature, the requirements for optimal tissue fixation and preservation, and the turnaround time for the experiments have prevented this technique from becoming widely used in the surgical pathology setting. The use of nonisotopic reporter molecules, the possibility of performing hybridization on archival material, and very recently, automation of the procedure have brought in situ hybridization to the forefront of diagnostic and experimental pathology. We describe our experience with nonradioactive, automated in situ hybridization, compare the technique with traditional manual procedures, and briefly outline its potential applications in diagnostic pathology and in the research setting.

[1]  M. Loda,et al.  The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. , 1997, Cancer research.

[2]  Hong Sun,et al.  The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine-phosphatase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Birnstiel,et al.  RNA-DNA Hybrids at the Cytological Level , 1969, Nature.

[4]  K. Kovacs,et al.  Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization. , 1991, The American journal of pathology.

[5]  M. Wigler,et al.  Cloning the differences between two complex genomes , 1993, Science.

[6]  J. Gray.  Molecular Cytogenetic Analysis of Human Tumors a , 1993, Annals of the New York Academy of Sciences.

[7]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[8]  L. Ailles,et al.  Transcription of cRNA for in situ hybridization from polymerase chain reaction-amplified DNA. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[9]  M. Loda,et al.  Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[10]  L. Rimsza,et al.  Rapid automated combined in situ hybridization and immunohistochemistry for sensitive detection of cytomegalovirus in paraffin-embedded tissue biopsies. , 1996, American journal of clinical pathology.

[11]  M. Loda,et al.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Gall,et al.  Formation and detection of RNA-DNA hybrid molecules in cytological preparations. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Loda,et al.  CDC25 phosphatases as potential human oncogenes. , 1995, Science.

[14]  Hong Sun,et al.  MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.

[15]  Kathryn Flynn,et al.  Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. , 1995, The New England journal of medicine.

[16]  J. Gall,et al.  Molecular hybridization of radioactive DNA to the DNA of cytological preparations. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Wolfe,et al.  High‐Specificity In‐Situ Hybridization Methods and Application , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[18]  C. Clavel,et al.  Comparison of four non-radioactive and 35S-based methods for the detection of human papillomavirus DNA by in situ hybridization. , 1991, Journal of virological methods.

[19]  B. Gusterson,et al.  Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Dixon,et al.  Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. , 1994, The Journal of biological chemistry.

[21]  S. Wolman.  Fluorescence in situ hybridization: a new tool for the pathologist. , 1994, Human pathology.

[22]  R. DeLellis.  In situ hybridization techniques for the analysis of gene expression: applications in tumor pathology. , 1994, Human pathology.

[23]  M. Loda,et al.  Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. , 1996, The American journal of pathology.

[24]  M. Loda,et al.  N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma). , 1993, Human pathology.

[25]  H. Pfister.  Human papillomaviruses and genital cancer. , 1987, Advances in cancer research.

[26]  A. Panoskaltsis-Mortari,et al.  In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. , 1995, BioTechniques.

[27]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[28]  A. Lazzarin,et al.  Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system , 1993, The Lancet.

[29]  H. Hausen,et al.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers , 1989 .

[30]  M. Loda,et al.  Thymosin β15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer , 1996, Nature Medicine.

[31]  A. Morey.  Non‐isotopic in situ hybridization at the ultrastructural level , 1995, The Journal of pathology.

[32]  M. Loda,et al.  Molecular events in the early phases of prostate carcinogenesis. , 1996, European urology.

[33]  C. Kessler,et al.  Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. , 1991, Analytical biochemistry.

[34]  Yunis Ej,et al.  Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues. , 1995 .

[35]  R. Ambinder,et al.  Epstein-Barr virus in AIDS-related primary central nervous system lymphoma , 1991, The Lancet.

[36]  J. Wilcox.  Fundamental principles of in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  K. Chan,et al.  Epstein‐barr virus carriage by nasopharyngeal carcinoma in situ , 1993, International journal of cancer.